Tenders

NHS National Generic Pharmaceuticals Wave 13

Closed

Submission Deadline Has Passed

This tender's submission deadline has passed and is no longer accepting applications. The information below is kept for reference purposes.

Browse Active Tenders
Deadline
Expired
December 30, 2021
Contract Details
Category
Other
Reference
001128-2022
Value
£192
Location
United Kingdom
Published
February 23, 2026
CPV Code
Project Timeline

Tender Published

January 14, 2022

Deadline for Questions

December 23, 2021

Submission Deadline

December 30, 2021

Budget
£192
Duration
Not specified
Location
United Kingdom
Type
Other

Original Tender Description

Potential periods of call-offs under the framework agreement:<br/><br/>Transition (Everolimus)<br/>CESW: 1 March 2022 – 30 September 2023 (19 months)<br/>LSNE: 1 March 2022 – 31 January 2023 (11 months)<br/>NWLN: 1 March 2022 – 31 January 2023 (11 months)<br/><br/>Oral Products plus non-parenterals<br/>All Regions: 1 March 2022 - 31 May 2024 (27 months)<br/><br/>Hospital Only Products<br/>CESW: 1 February 2022 – 30 September 2023 (20 months)<br/>LSNE: 1 February 2022 – 31 May 2024 (28 months)<br/>NWLN: 1 February 2022 – 31 January 2023 (12 months)

Risk Analysis

Please log in to use risk analysis.

Login

Win Strategy

Please log in to access winning strategy recommendations.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI requirements analysis not yet available for this tender.

Requirements will be generated automatically when tender documents are processed.


Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

No processed documents available for this tender.

Documents will appear here once they are downloaded and analyzed.

Analysis Pending

Quality analysis for this tender is being processed. Please check back shortly.

Add to Pipeline